Academic Journal

PD13-11 ADDITIONAL NOVEL CYTOREDUCTIVE TREATMENTS TO THE PRIMARY TUMOUR AND METASTASIS FOR DE NOVO METASTATIC-HORMONE SENSITIVE PROSTATE CANCER (IP2-ATLANTA): THE INTERNAL PILOT OUTCOMES OF A PHASE II, MULTICENTRE, RANDOMISED CONTROLLED TRIAL

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τίτλος: PD13-11 ADDITIONAL NOVEL CYTOREDUCTIVE TREATMENTS TO THE PRIMARY TUMOUR AND METASTASIS FOR DE NOVO METASTATIC-HORMONE SENSITIVE PROSTATE CANCER (IP2-ATLANTA): THE INTERNAL PILOT OUTCOMES OF A PHASE II, MULTICENTRE, RANDOMISED CONTROLLED TRIAL
Συγγραφείς: Martin J. Connor, Taimur T. Shah, Johanna Sukumar, Dolan Basak, Francesca Fiorentino, Catherine Heath, Gail Horan, Nicholas Johnson, Vincent Khoo, Bijan Khoubehi, Natalia Klimowska-Nassar, Stephen Mangar, John McGrath, Consuelo Nohpal De La Rosa, Derek Price, Bhavan Rai, Naveed Sarwar, Smith Andrew, John N. Staffurth, Kamalran Thippu Jayaprakash, Mathias Winkler, Tim Dudderidge, Hashim U. Ahmed
Πηγή: Journal of Urology. 213
Στοιχεία εκδότη: Ovid Technologies (Wolters Kluwer Health), 2025.
Έτος έκδοσης: 2025
Τύπος εγγράφου: Article
Γλώσσα: English
ISSN: 1527-3792
0022-5347
DOI: 10.1097/01.ju.0001109880.25183.6b.11
Αριθμός Καταχώρησης: edsair.doi...........e2ed3c32b6cfa68ca48cb0aa12bc893d
Βάση Δεδομένων: OpenAIRE